Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Precise Cancer Surgeries and Drug Treatments: Tumor Paint, Peptides and PDX Models

Reporter: Aviva Lev-Ari, PhD, RN

LISTEN TO AUDIO

http://www.healthtech.com/Conferences_Content.aspx?id=140493

Precise Cancer Surgeries and Drug Treatments: Tumor Paint, Peptides and PDX Models

James M. Olson, M.D., Ph.D., Member, Clinical Research Division, Fred Hutchinson Cancer Research Center; Professor, Pediatric Hematology

and Oncology, University of Washington; Attending Physician, Seattle Children’s Hospital; Founder, Presage Biosciences and Blaze Bioscience

Dr. Olson will be a plenary keynote speaker at the CHI’s upcoming 6th Annual Leaders in Biobanking Congress and the Inaugural

Cancer Diagnosis at the Crossroads: Precision Medicine Driving Change event, September 15-17 in Seattle, WA.

Leaders in Biobanking Agenda | Cancer Diagnosis Agenda

Ways to Register:

On-line: click here.

By Phone:

781.972.5400

For Group Discounts, Contact:

David Cunningham

Phone: 781.972.5472

Email: Cunningham@healthtech.com

SOURCE

From: Leaders in Biobanking <kerris@healthtech.com>
Date: Fri, 08 Aug 2014 12:40:48 -0400
To: <avivalev-ari@alum.berkeley.edu>
Subject: Complimentary Podcast on Precise Cancer Surgeries